Request Deal Involvement

Goldman Sachs led a $93.5m Series A round in Newleos Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

NEWLEOS THERAPEUTICS INC

target

NEWLEOS THERAPEUTICS INC

GOLDMAN SACHS ALTERNATIVES

bidder

GOLDMAN SACHS ALTERNATIVES

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

LONGWOOD FUND

bidder

LONGWOOD FUND

DCVC BIO

bidder

DCVC BIO

ARKIN BIO VENTURES

bidder

ARKIN BIO VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Goldman Sachs led a $93.5m Series A round in Newleos Therapeutics.